A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
Clinical trial NCT07540364 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07540364
- Sponsor
- Suven Life Sciences Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-19
- Primary completion
- 2027-11-19
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.